Publicaciones en colaboración con investigadores/as de Instituto IMDEA Alimentación (21)

2024

  1. Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks

    Current Obesity Reports, Vol. 13, Núm. 3, pp. 461-474

  2. Bridging Metabolic-Associated Steatotic Liver Disease and Cardiovascular Risk: A Potential Role for Ketogenesis

    Biomedicines, Vol. 12, Núm. 3

  3. Circulating miR-122-5p, miR-151a-3p, miR-126-5p and miR-21-5p as potential predictive biomarkers for Metabolic Dysfunction-Associated Steatotic Liver Disease assessment

    Journal of Physiology and Biochemistry

2023

  1. Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome

    Biomedicine and Pharmacotherapy, Vol. 161

  2. Dietary Iron, Anemia Markers, Cognition, and Quality of Life in Older Community-Dwelling Subjects at High Cardiovascular Risk

    Nutrients, Vol. 15, Núm. 20

  3. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset

    European Journal of Clinical Investigation, Vol. 53, Núm. 10

  4. Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases

    BioFactors, Vol. 49, Núm. 4, pp. 912-927

  5. Repercussions of absolute and time-rated BMI “yo-yo” fluctuations on cardiovascular stress-related morbidities within the vascular-metabolic CUN cohort

    Frontiers in Endocrinology, Vol. 13

  6. Treatment with the senolytics dasatinib/quercetin reduces SARS-CoV-2-related mortality in mice

    Aging Cell, Vol. 22, Núm. 3

2022

  1. Diagnostic scores and scales for appraising Nonalcoholic fatty liver disease and omics perspectives for precision medicine

    Current Opinion in Clinical Nutrition and Metabolic Care, Vol. 25, Núm. 5, pp. 285-291

  2. Longwise Cluster Analysis for the Prediction of COVID-19 Severity within 72 h of Admission: COVID-DATA-SAVE-LIFES Cohort

    Journal of Clinical Medicine, Vol. 11, Núm. 12

  3. Machine learning insights concerning inflammatory and liver-related risk comorbidities in non-communicable and viral diseases

    World Journal of Gastroenterology, Vol. 28, Núm. 44, pp. 6230-6248

  4. The Role of Nutrition on Meta-inflammation: Insights and Potential Targets in Communicable and Chronic Disease Management

    Current Obesity Reports, Vol. 11, Núm. 4, pp. 305-335

2021

  1. A Mediterranean lifestyle reduces the risk of cardiovascular disease in the “Seguimiento Universidad de Navarra” (SUN) cohort

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 31, Núm. 6, pp. 1728-1737

  2. Interactions of comorbidity and five simple environmental unhealthy habits concerning physical and mental quality of life in the clinical setting

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 18

  3. Proinflammatory and hepatic features related to morbidity and fatal outcomes in covid-19 patients

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2020

  1. Exploring host genetic polymorphisms involved in SARS-CoV infection outcomes: Implications for personalized medicine in covid-19

    International Journal of Genomics, Vol. 2020

2019

  1. Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease: A comparison with healthy controls

    Nutrients, Vol. 11, Núm. 2

  2. MicroRNA 7 impairs insulin signaling and regulates Aβ levels through posttranscriptional regulation of the insulin receptor substrate 2, insulin receptor, insulin-degrading enzyme, and liver X receptor pathway

    Molecular and Cellular Biology, Vol. 39, Núm. 22

  3. Ultrasound/elastography techniques, lipidomic and blood markers compared to magnetic resonance imaging in non-alcoholic fatty liver disease adults

    International Journal of Medical Sciences, Vol. 16, Núm. 1, pp. 75-83